Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019469
Filing Date
2021-08-12
Accepted
2021-08-12 14:27:52
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 643797
2 ex31-1.htm EX-31.1 10926
3 ex32-1.htm EX-32.1 4355
  Complete submission text file 0001493152-21-019469.txt   8264923

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nphc-20200930.xml EX-101.INS 1340996
5 XBRL SCHEMA FILE nphc-20200930.xsd EX-101.SCH 61405
6 XBRL CALCULATION FILE nphc-20200930_cal.xml EX-101.CAL 74796
7 XBRL DEFINITION FILE nphc-20200930_def.xml EX-101.DEF 282166
8 XBRL LABEL FILE nphc-20200930_lab.xml EX-101.LAB 436730
9 XBRL PRESENTATION FILE nphc-20200930_pre.xml EX-101.PRE 380540
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 211167000
SIC: 2833 Medicinal Chemicals & Botanical Products